Literature DB >> 11934563

Characteristics of Staphylococcus aureus, isolated from airways of cystic fibrosis patients, and their small colony variants.

Beata Sadowska1, Agnieszka Bonar, Christof von Eiff, Richard A Proctor, Magdalena Chmiela, Wieslawa Rudnicka, Barbara Róźalska.   

Abstract

The colonization of respiratory tract by Staphylococcus aureus is a frequent feature of cystic fibrosis (CF), especially in pediatric patients. The formation of small colony variants (SCVs), which produce reduced amounts of alpha-toxin, is one of the proposed ways of staphylococcal accommodation in an intracellular niche. The aim of the present study was to compare some properties of S. aureus SCVs and their parent strains. A site-directed S. aureus hemB mutant and parent strain 8325-4 were included in the study (control pair). Normal and SCV strain pairs from CF patients as well as control strains were tested for the susceptibility to defensins, killing activity of professional phagocytes and adhesion to A549 cell line. Because S. aureus are exposed to many cationic proteins in the host, we challenged a clinical isolate with minimal subinhibitory concentration (subMIC) of protamine and found that hemin and menadione auxotrophic SCVs emerged. SCVs were more resistant than normal strains to protamine but not to dermaseptin. The susceptibility to the bactericidal activity of magainin was the same for normal and SCV strains. The protamine resistance of normal as well as SCVs was strongly enhanced by high salt concentration. The adhesion of some SCVs to A549 cells was higher than adhesion of parental strains. However, the number of adherent bacteria (SCVs) was diminished in the presence of hemin for hemin auxotrophs. The uptake of SCVs by granulocytes was lower than ingestion of normal strains, but SCVs were killed with equal or greater potency. SCVs are adapted to intracellular survival and persistence in the host under certain circumstances. The ability to form a variant subpopulation affords S. aureus additional survival options.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11934563     DOI: 10.1111/j.1574-695X.2002.tb00553.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  39 in total

1.  sigmaB activity in a Staphylococcus aureus hemB mutant.

Authors:  Maria M Senn; Markus Bischoff; Christof von Eiff; Brigitte Berger-Bächi
Journal:  J Bacteriol       Date:  2005-11       Impact factor: 3.490

2.  Bacterial interactions and the microevolution of cytochrome bd: implications for pathogenesis.

Authors:  Peter J McNamara; Richard A Proctor
Journal:  J Bacteriol       Date:  2006-12       Impact factor: 3.490

3.  Intra- and extracellular activities of dicloxacillin and linezolid against a clinical Staphylococcus aureus strain with a small-colony-variant phenotype in an in vitro model of THP-1 macrophages and an in vivo mouse peritonitis model.

Authors:  Anne Sandberg; Sandrine Lemaire; Françoise Van Bambeke; Paul M Tulkens; Diarmaid Hughes; Christof von Eiff; Niels Frimodt-Møller
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

Review 4.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

5.  Ecological advantages of autolysis during the development and dispersal of Pseudoalteromonas tunicata biofilms.

Authors:  Anne Mai-Prochnow; Jeremy S Webb; Belinda C Ferrari; Staffan Kjelleberg
Journal:  Appl Environ Microbiol       Date:  2006-08       Impact factor: 4.792

Review 6.  Heme Synthesis and Acquisition in Bacterial Pathogens.

Authors:  Jacob E Choby; Eric P Skaar
Journal:  J Mol Biol       Date:  2016-03-24       Impact factor: 5.469

7.  Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype and revertant strains.

Authors:  Hoang Anh Nguyen; Olivier Denis; Anne Vergison; Anne Theunis; Paul M Tulkens; Marc J Struelens; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

8.  Staphylococcus aureus sigma B-dependent emergence of small-colony variants and biofilm production following exposure to Pseudomonas aeruginosa 4-hydroxy-2-heptylquinoline-N-oxide.

Authors:  Gabriel Mitchell; David Lalonde Séguin; Ann-Elise Asselin; Eric Déziel; André M Cantin; Eric H Frost; Sophie Michaud; François Malouin
Journal:  BMC Microbiol       Date:  2010-01-30       Impact factor: 3.605

9.  Influence of dTMP on the phenotypic appearance and intracellular persistence of Staphylococcus aureus.

Authors:  Johannes Zander; Silke Besier; Stephan H Saum; Faramarz Dehghani; Stefan Loitsch; Volker Brade; Thomas A Wichelhaus
Journal:  Infect Immun       Date:  2007-12-26       Impact factor: 3.441

10.  The mutated staphylococcal H35A α-toxin inhibits adhesion and invasion of Staphylococcus aureus and group A streptococci.

Authors:  Junshu Yang; Xudong Liang; Yinduo Ji
Journal:  Virulence       Date:  2013-01-01       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.